ArticleCancer research2022

Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.

Toni M Brand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.